# Corcept Therapeutics Inc: Form 8-K, filed Dec 11, 2023

- Company: [Corcept Therapeutics Inc](/companies/cort.md) (CIK 1088856)
- Form: 8-K
- Filed: 2023-12-11
- Accepted by EDGAR: Dec 11, 2023, 16:34 ET
- Period: 2023-12-05
- Accession: 0001193125-23-292621
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/d833600d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1088856/000119312523292621/d833600d8k.htm

Filed Dec 11, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-292621. Last ingested by Listed: Nov 14, 2026, 21:12 ET. No prices; not investment advice.
